This cohort study uses linked registry data to investigate the biological and clinical progression of cancer associated with sociodemographic data and screening vs symptomatic detection in women with nonmetastatic invasive estrogen receptor–positive breast cancers. This evidence concerns the gene ESR1 and breast cancer.